NGNE vs TAP · $286.5M cap vs rev $13.04B
Neurogene Inc (NGNE) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
TAP (TAP) common stock.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
Latest reported TAP revenue for 2025-12-31 was $13.04B. Net income was -$2.14B. Revenue was down 5.1% from 2024-12-31 to 2025-12-31. TAP currently screens at market cap $0.
NGNE currently screens at market cap $286.5M. TAP currently screens at market cap $0.
Not investment advice. Open the NGNE and TAP stock pages for the full models.
Not investment advice.